ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Caverject 20 ug, Injektionspräparat - 1 + Durchstechflasche(n)
52510105 Pfizer AG
Caverject 20 ug, Injektionspräparat21.10.1994
  30.04.2013
Alprostadil (G04BE01)18.02.2004
WHO-DDD 
02.04.50.1 + Durchstechflasche(n)
05.99. 
A  
No 
IPCI
PR  
k.A.PR
  
7680525101050Synthetika
  
Composition
Praeparatio cryodesiccata: alprostadilum 20 µg, lactosum monohydricum, alfadexum, natrii citras dihydricus, acidum hydrochloridum aut natrii hydroxidum, pro vitro. Solvens: conserv.: alcohol benzylicus 8.4 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Praeparatio cryodesiccata:
Injection preparation
 
 
Active AgentDose
Alprostadil20 µg
 
Inactive agents
Acidum Hydrochloridum aut Natrii Hydroxidum
Alfadexum
Lactose Monohydrate
Natrii Citras Dihydricus
Solvens
Injection preparation
 
  
 
Inactive agentsDoseadditional_information
Alcohol Benzylicus8.4 mg/mlconserv.
Source
Data was imported : 07.07.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home